L&T may test Rs 2150: Gujral

7170 Investors following GlaxoSmithKline. Share this News with them.

0

Like this story, share it with millions of investors on M3

L&T may test Rs 2150: Gujral

Technical Analyst, Ashwani Gujral is of the view that L&T may test Rs 2150.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Bazaar on CNBC-TV18 Watch the full show » ALSO READ See previous views by Ashwani Gujral See what other Experts & Brokerages are saying about GlaxoSmithKline See messages about GlaxoSmithKline GlaxoSmithKline BSE | NSE 28/05/12 Are Mutual Funds betting on GlaxoSmithKline? Other Stocks in this news HDFC Bank | Larsen and Toubro |

Technical Analyst, Ashwani Gujral is of the view that Larsen and Toubro , L&T may test Rs 2150.

Gujral told CNBC-TV18, "Reliance could now start moving sideways. I think the market has enough to keep it up because stocks like BHEL, ABB, these stocks are making new highs. L &T made a new high yesterday and that is probably headed towards Rs 2,150 and Glaxo has broken out and now headed for Rs 1,460. HDFC Bank is looking strong. So you could have a sideways move on the large cap indices but more action will shift towards midcaps."